We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
AUM
$365M
AUM Growth
+$46.1M
Cap. Flow
+$37.6M
Cap. Flow %
10.3%
Top 10 Hldgs %
19.35%
Holding
1,326
New
84
Increased
304
Reduced
473
Closed
56

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.44M
2
ORCL icon
Oracle
ORCL
+$1.05M
3
ETP
Energy Transfer Partners L.p.
ETP
+$657K
4
HDB icon
HDFC Bank
HDB
+$522K
5
BA icon
Boeing
BA
+$473K

Sector Composition

Rank Sector Weight
1 Technology 19.43%
2 Healthcare 11.88%
3 Financials 10.98%
4 Consumer Discretionary 8.56%
5 Energy 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFCFA
651
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$32.5K 0.01%
1,146
+446
+64% +$12.8K
DON icon
652
WisdomTree US MidCap Dividend Fund
DON
$4.03B
$32.3K 0.01%
990
EIX icon
653
Edison International
EIX
$30.7B
$32.1K 0.01%
411
-1
-0.2% -$80
SLV icon
654
iShares Silver Trust
SLV
$28.1B
$31.8K 0.01%
2,000
+500
+33% +$8.14K
HEFA icon
655
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.47B
$31.7K 0.01%
1,115
-1
-0.1% -$28
DLN icon
656
WisdomTree US LargeCap Dividend Fund
DLN
$6.24B
$31.5K 0.01%
750
+598
+393% +$25K
MVF
657
DELISTED
BlackRock MuniVest Fund
MVF
$31.5K 0.01%
3,250
AMPH icon
658
Amphastar Pharmaceuticals
AMPH
$825M
$31.4K 0.01%
1,758
PJP icon
659
Invesco Pharmaceuticals ETF
PJP
$425M
$31.4K 0.01%
500
-40
-7% -$2.4K
CB icon
660
Chubb
CB
$140B
$31.3K 0.01%
215
-1
-0.5% -$141
USO icon
661
United States Oil Fund
USO
$2.27B
$31.2K 0.01%
410
MKC icon
662
McCormick & Company Non-Voting
MKC
$13.4B
$31K 0.01%
636
-112
-15% -$5.67K
TRST
663
Trustco Bank Corp NY
TRST
$977M
$31K 0.01%
800
DISCK
664
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$30.8K 0.01%
1,223
-1
-0.1% -$26
BXP icon
665
Boston Properties
BXP
$11B
$30.8K 0.01%
250
SUSA icon
666
iShares ESG Optimized MSCI USA ETF
SUSA
$3.98B
$30.7K 0.01%
600
GMLP
667
DELISTED
Golar LNG Partners LP
GMLP
$30.6K 0.01%
1,400
-10,476
-88% -$221K
NLY icon
668
Annaly Capital Management
NLY
$16.9B
$30.4K 0.01%
+631
New +$29.8K
LMT icon
669
Lockheed Martin
LMT
$134B
$30.3K 0.01%
109
-1
-0.9% -$275
BLMN icon
670
Bloomin' Brands
BLMN
$680M
$30.3K 0.01%
1,425
-1
-0.1% -$21
MKL icon
671
Markel Group
MKL
$25B
$30.3K 0.01%
+31
New +$30.1K
MPT
672
Medical Properties Trust
MPT
$2.89B
$29.9K 0.01%
2,325
+449
+24% +$5.98K
LSXMK
673
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$29.8K 0.01%
937
PCY icon
674
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
$29.5K 0.01%
1,009
+711
+239% +$20.9K
XSW icon
675
State Street SPDR S&P Software & Services ETF
XSW
$417M
$28.9K 0.01%
460

Similar funds

Winslow Evans & Crocker's Q2 2017 Portfolio in Review

As of Q2 2017, Winslow Evans & Crocker held 1,326 positions worth $365M, up 14% from $318M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Winslow Evans & Crocker deployed $37.6M of net new capital in Q2 2017, opening 84 new positions and adding to 304 existing holdings. Its largest new stake was Idexx Laboratories: 3,900 shares worth $629K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Allergan plc, an estimated $3.44M trimmed.

  • Winslow Evans & Crocker's largest Q2 2017 buy was Idexx Laboratories: 3,900 shares worth $629K.
  • Winslow Evans & Crocker added most to Microsoft in Q2 2017, an estimated $3.28M increase.
  • Winslow Evans & Crocker's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $3.44M.
  • Winslow Evans & Crocker fully exited State Street Energy Select Sector SPDR ETF in Q2 2017, selling an estimated $428K.
  • Winslow Evans & Crocker's ten largest holdings make up 19% of its $365M portfolio in Q2 2017.
  • Winslow Evans & Crocker opened 84 new positions and closed 56 in Q2 2017.
  • Winslow Evans & Crocker's portfolio value rose 14% quarter-over-quarter to $365M.

Based on Winslow Evans & Crocker's 13F filing for Q2 2017, filed 14 Jul 2017.